Jpmorgan Chase & Co »

ALNYLAM PHARMACEUTICALS INC. Common Stock cmn shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of ALNYLAM PHARMACEUTICALS INC. Common Stock cmn shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in ALNYLAM PHARMACEUTICALS INC. Common Stock cmn

Tip: Access up to 7 years of quarterly data

All positions including ALNYLAM PHARMACEUTICALS INC. Common Stock cmn held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ALNYLAM PHARMACEUTICALS INC. Common Stock cmn by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $12M 63k 191.41
2023-09-30 $7.1M 40k 177.10
2023-06-30 $9.5M 50k 189.94
2023-03-31 $10M 50k 200.32
2022-12-31 $9.5M 40k 237.65
2022-06-30 $1.7M 12k 145.88
2022-03-31 $1.9M 12k 163.28
2021-12-31 $14M 83k 169.58
2020-03-31 $2.2M 20k 108.85
2019-03-31 $1.7M 18k 93.44
2018-09-30 $2.6M 30k 87.53
2018-06-30 $2.7M 27k 98.48
2018-03-31 $3.2M 27k 119.11

Top funds holding ALNYLAM PHARMACEUTICALS INC. Common Stock cmn